STOCKHOLDERS’ EQUITY

9 Months Ended

Dec. 31, 2024

Stockholders' Equity Note [Abstract]

STOCKHOLDERS’ EQUITY

STOCKHOLDERS’ EQUITY

Stock Repurchase Program. The Company’s Board of Directors (Board) has approved various authorizations under the Company’s stock repurchase program to repurchase shares of its common stock in the open market or in privately negotiated transactions, subject to market conditions, applicable legal requirements, and other factors (collectively, the stock repurchase program). As of December 31, 2024, the aggregate remaining approved amount under the stock repurchase program is $640,692. The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be suspended at any time at the Company’s discretion.

Stock repurchase activity under the Company’s stock repurchase program was as follows:

	Nine Months Ended December 31,
	2024		2023
Total number of shares repurchased (1)	2,022,299		3,573,960
Weighted average price per share paid	$	148.85	$	86.92
Dollar value of shares repurchased (2) (3)	$	301,011	$	310,635

(1) All share repurchases were made pursuant to the Company’s stock repurchase program in open-market transactions.

(2) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs.

(3) May not calculate on rounded dollars.

Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the condensed consolidated balance sheets, are as follows:

	December 31, 2024		March 31, 2024
Unrealized gain on cash flow hedges	$	2,555	$	—
Cumulative foreign currency translation loss	(57,999)		(50,733)
Total	$	(55,444)	$	(50,733)